2007
DOI: 10.1002/chin.200719224
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Development of Dopaminergic Aporphinoids

Abstract: ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
42
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(43 citation statements)
references
References 1 publication
1
42
0
Order By: Relevance
“…A wide spectrum of biological activities have been reported for all three alkaloids, and their core structures have been used to develop lead molecules for potential treatments against a variety of diseases (Zhang et al, 2007;Jadhav et al, 2010). For example, the protoberberine skeleton has been used to develop antibacterial agents (Jadhav et al, 2010), and bulbocapnine possesses dopamine D 2 receptor antagonist properties (Zhang et al, 2007). These three alkaloids are also present in several traditional Chinese medicine preparations (Salminen et al, 2011b).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A wide spectrum of biological activities have been reported for all three alkaloids, and their core structures have been used to develop lead molecules for potential treatments against a variety of diseases (Zhang et al, 2007;Jadhav et al, 2010). For example, the protoberberine skeleton has been used to develop antibacterial agents (Jadhav et al, 2010), and bulbocapnine possesses dopamine D 2 receptor antagonist properties (Zhang et al, 2007). These three alkaloids are also present in several traditional Chinese medicine preparations (Salminen et al, 2011b).…”
Section: Discussionmentioning
confidence: 99%
“…Protopine is present, e.g., in preparations from the medicinal plant Fumaria officinalis, which is included in the European Pharmacopoeia (Vrba et al, 2011). A wide spectrum of biological activities have been reported for all three alkaloids, and their core structures have been used to develop lead molecules for potential treatments against a variety of diseases (Zhang et al, 2007;Jadhav et al, 2010). For example, the protoberberine skeleton has been used to develop antibacterial agents (Jadhav et al, 2010), and bulbocapnine possesses dopamine D 2 receptor antagonist properties (Zhang et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, aporphines with an alpha C6a hydrogen such as bulbocapnine (CS 1.216), boldine, and glaucine are dopamine receptor antagonists, such as the dopaminergic receptor subtypes 1/2 (D 1 /D 2 ), 379,380 whereas the presence of a beta C6a hydrogen produces agonists, such as notably D 1 /D 2 . Indeed, aporphines with an alpha C6a hydrogen such as bulbocapnine (CS 1.216), boldine, and glaucine are dopamine receptor antagonists, such as the dopaminergic receptor subtypes 1/2 (D 1 /D 2 ), 379,380 whereas the presence of a beta C6a hydrogen produces agonists, such as notably D 1 /D 2 .…”
Section: Rationalementioning
confidence: 99%
“…Glaucine shows antitussive, bronchodilatory and anti‐inflammatory properties and acts also as weak dopamine D 1 and D 2 receptor antagonist . The antitussive properties of glaucine are comparable to codeine without signs of opiate withdrawal after longer intake . It is used as a therapeutic drug in Bulgaria and other countries as cough suppressant.…”
Section: Introductionmentioning
confidence: 99%